Ftse Mib
33.294,96
0,20%
DAX
19.146,17
0,76%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.141,25
-0,38%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Belite Bio Inc (BLTE) Belite Bio Inc (BLTE) Notizie

Belite Bio Inc

BLTE
82,45
-0,08 (-0,10%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:40:58
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202400:25EDGAR2Form 144 - Report of proposed sale of securities
20/11/202400:17EDGAR2Form 144 - Report of proposed sale of securities
12/11/202407:00GLOBEBelite Bio Reports Third Quarter 2024 Financial Results and..
05/11/202414:00GLOBEBelite Bio to Host Webcast on November 12, 2024, to Discuss..
04/11/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202422:00GLOBEBelite Bio Announces Exercise of Warrants for US$28.75..
14/10/202414:00GLOBEBelite Bio Announces Presentations at the American Academy..
08/10/202423:48EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
08/10/202414:00GLOBEBelite Bio to Participate in the Maxim Group 2024 Healthcare..
04/10/202402:50EDGAR2Form 144 - Report of proposed sale of securities
04/10/202402:48EDGAR2Form 144 - Report of proposed sale of securities
01/10/202412:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/9/202414:51GLOBEDeutsche Bank ADR Virtual Investor Conference: Presentations..
20/9/202418:40EDGAR2Form 144 - Report of proposed sale of securities
17/9/202417:22GLOBEInternational companies to host live webcasts at Deutsche..
10/9/202414:00GLOBEBelite Bio Announces First Patient Dosed in Phase 2/3 DRAGON..
04/9/202418:29EDGAR2Form 144 - Report of proposed sale of securities
03/9/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/9/202414:00GLOBEBelite Bio to Participate in Three Upcoming Investor..
01/9/202414:00GLOBEBelite Bio Announces Appointment of Hendrik P. N. Scholl,..
17/8/202400:24EDGAR2Form 144 - Report of proposed sale of securities
14/8/202422:32EDGAR2Form 144 - Report of proposed sale of securities
14/8/202422:30EDGAR2Form 144 - Report of proposed sale of securities
14/8/202420:38EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/8/202422:30GLOBEBelite Bio Reports Second Quarter 2024 Financial Results and..
08/8/202414:00GLOBEBelite Bio to Present at the H.C. Wainwright 4th Annual..
06/8/202401:10GLOBEBelite Bio to Host Webcast on August 12, 2024, to Discuss..
08/7/202414:00GLOBEBelite Bio to Present at the JonesHealthcare Seaside Summit
12/6/202408:55GLOBEBelite Bio Receives Sakigake (Pioneer Drug) Designation of..
04/6/202421:17EDGAR2Form 144 - Report of proposed sale of securities
30/5/202422:45EDGAR2Form 144 - Report of proposed sale of securities
17/5/202417:36EDGAR2Form 144 - Report of proposed sale of securities
16/5/202420:23EDGAR2Form 144 - Report of proposed sale of securities
14/5/202414:00GLOBEBelite Bio to Participate in the Benchmark’s 4th Annual..
14/5/202403:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202403:50GLOBEBelite Bio Reports First-Quarter 2024 Financial Results and..
13/5/202414:00GLOBEBelite Bio to Participate in the H.C. Wainwright 2nd Annual..
08/5/202414:00GLOBEBelite Bio to Host Webcast on May 14, 2024, to Discuss First..
06/5/202414:15GLOBEBelite Bio to Participate in Key Opinion Leader Webinar to..
06/5/202414:00GLOBEBelite Bio Presents Additional Analysis from Phase 2 Study..
01/5/202422:15GLOBEBelite Bio Announces Presentation at the Association for..
26/4/202401:15GLOBEBelite Bio Announces $25 Million Registered Direct Offering
22/3/202413:00GLOBEBelite Bio Announces PMDA Submission of Tinlarebant for..
12/3/202403:28GLOBEBelite Bio Announces Availability of Annual Report on Form..
12/3/202402:27GLOBEBelite Bio Reports Fourth Quarter and Full Year 2023..
06/3/202414:00GLOBEBelite Bio to Host Webcast on March 12, 2024, to Discuss..
04/3/202414:00GLOBEBelite Bio to Participate in the Leerink Partners Global..
13/2/202403:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202402:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: 82,81 Min: 81,10 Max: 82,81
Chiusura: 82,53

La tua Cronologia

NASDAQ
BLTE
Belite Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network